Monday, December 23, 2024
HomeTagsGastroesophageal Junction Cancer

Gastroesophageal Junction Cancer

FDA Granted CMG901 Fast Track Designation for Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer

Keymed Biosciences announced that the U.S. Food and Drug Administration (FDA) granted CMG901 Fast Track Designation as monotherapy for the treatment of unresectable or...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics